Christian Behrenbruch is the Managing Director and Group Chief Executive Officer at Telix Pharmaceuticals. Based in North Melbourne, Victoria, Australia.
Christian Behrenbruch is the Managing Director and Group Chief Executive Officer at Telix Pharmaceuticals. Telix Pharmaceuticals develops radiopharmaceuticals and has a late-stage clinical product pipeline. The company recently completed a $175 million institutional placement and launched a Share Purchase Plan to raise an additional $25 million in January 2022. Behrenbruch has over two decades of experience in radiopharmaceuticals and a background in global healthcare and biotechnology entrepreneurship.
Full founder directory · Investor directory · Company funding database · Fundraising library